Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Nov 30;8(5):132-135.
doi: 10.1002/cld.588. eCollection 2016 Nov.

Novel treatments in primary sclerosing cholangitis

Affiliations
Review

Novel treatments in primary sclerosing cholangitis

Ahmad H Ali et al. Clin Liver Dis (Hoboken). .
No abstract available

PubMed Disclaimer

References

    1. Hirschfield GM, Karlsen TH, Lindor KD, Adams DH. Primary sclerosing cholangitis. Lancet 2013;382:1587‐1599. - PubMed
    1. Boonstra K, Beuers U, Ponsioen CY. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. J Hepatol 2012;56:1181‐1188. - PubMed
    1. Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, et al; American Association for the Study of Liver Diseases . Diagnosis and management of primary sclerosing cholangitis. Hepatology 2010;51:660‐678. - PubMed
    1. Olsson R, Boberg KM, de Muckadell OS, Lindgren S, Hultcrantz R, et al. High‐dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5‐year multicenter, randomized, controlled study. Gastroenterology 2005;129:1464‐1472. - PubMed
    1. Lindor KD, Kowdley KV, Luketic VA, Harrison ME, McCashland T, et al. High‐dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis. Hepatology 2009;50:808‐814. - PMC - PubMed